Advertisement

Topics

PPIs or H2RAs to Prevent Rebleeding in Patients Taking Aspirin?

20:00 EDT 22 Sep 2016 | NEJM

Risk for rebleeding was similar with a proton-pump inhibitor or an H2-receptor antagonist in an underpowered study.

Original Article: PPIs or H2RAs to Prevent Rebleeding in Patients Taking Aspirin?

NEXT ARTICLE

More From BioPortfolio on "PPIs or H2RAs to Prevent Rebleeding in Patients Taking Aspirin?"

Quick Search
Advertisement